P-044
异丙嗪 盐酸盐
vial of 25 mg, certified reference material, Cerilliant®
别名:
10-(2-二甲基氨基-1-丙基)吩噻嗪 盐酸盐
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C17H20N2S · HCl
化学文摘社编号:
分子量:
320.88
EC Number:
200-375-2
UNSPSC Code:
41116107
PubChem Substance ID:
Beilstein/REAXYS Number:
4166397
MDL number:
grade
certified reference material
Quality Level
form
solid
feature
Snap-N-Spike®/Snap-N-Shoot®
packaging
vial of 25 mg
manufacturer/tradename
Cerilliant®
technique(s)
gas chromatography (GC): suitable, liquid chromatography (LC): suitable
application(s)
forensics and toxicology
pharmaceutical (small molecule)
format
neat
storage temp.
room temp
SMILES string
Cl[H].CC(CN1c2ccccc2Sc3ccccc13)N(C)C
InChI
1S/C17H20N2S.ClH/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19;/h4-11,13H,12H2,1-3H3;1H
InChI key
XXPDBLUZJRXNNZ-UHFFFAOYSA-N
Gene Information
human ... HRH1(3269)
General description
Promethazine is a phenothiazine analog prescribed for treatment of motion sickness, nausea, vomiting and allergies. This Certified Reference Material is suitable for GC/MS or LC/MS methods in promethazine testing for forensic analysis, urine drug testing, or clinical toxicology. Sold under the trade names Phenergan® and Phenadoz®, promethazine has antihistamine, sedative, and mild antipsychotic effects. The compound has also been been found in the recreational drug "Purple Drank."
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Phenadoz is a registered trademark of Watson Laboratories, Inc.
Phenergan is a registered trademark of Delcor Asset Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 异丙嗪 盐酸盐
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Gaeul Han et al.
Current issues in molecular biology, 43(3), 1669-1684 (2021-10-27)
Postmenopausal syndrome refers to symptoms caused by the gradual decrease in female hormones after mid-40 years. As a target organ of estrogen, decrease in estrogen causes various changes in brain function such as a decrease in choline acetyltransferase and brain-derived
Elisa Izquierdo et al.
Cancer discovery (2021-11-06)
The survival of children with DIPG remains dismal, with new treatments desperately needed. In a prospective biopsy-stratified clinical trial, we combined detailed molecular profiling and drug screening in newly-established patient-derived models in vitro and in vivo. We identified in vitro
Mario Schietroma et al.
Journal of the American College of Surgeons, 220(5), 921-933 (2015-04-05)
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. An independent statistical analysis based on the summary data tables and statistical results reported in the